Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02464228
Title Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kura Oncology, Inc.
Age Groups: adult
Covered Countries USA | ESP

No variant requirements are available.